Two new modifications, alpha ' -SrAlF5 and delta -BaAlF5, as well as two so
lid solutions, Ca0.08Sr0.92AlF5 and Ca0.33Sr0.67AlF5, have been synthesized
in the system (M, M ' )F-2/AlF3 with M, M ' = Ca, Sr, Ba. The preparation
of single crystals has been performed under hydrothermal conditions and sol
id state reactions, respectively. All crystal structures have been refined
from single crystal diffractometer data. A common feature of the structures
are the corner linked AlF6 octahedra forming chains [AlF4/1F2/2]. alpha '
-SrAlF5 is the second well characterized modification known up until now ha
ving this composition. Its crystal structure (P2(1)/n (No. 14), a = 8.9574(
5), b = 7.4614(4), c = 10.7212(6) Angstrom, beta = 94.158(1)degrees, Z = 8,
R[F-2 > 2 sigma (F-2)] = 0.020, omegaR(2)(F-2 all) = 0.045) is isotypic wi
th alpha ' -BaFeF5. Incorporation of small amounts of calcium into the stru
cture leads to the solid solution Ca0.08Sr0.92AlF5 (P21/n (No. 14), a = 8.9
351(7), b = 7.4387(6), c = 10.6845(8) Angstrom, beta = 94.194(2)degrees, Z
= 8, R[F-2 > 2 sigma (F-2)] = 0.025, omegaR(2)(F-2 all) = 0.053) with sligh
tly smaller lattice parameters. Increase of the calcium amount in the SrAlF
5 host lattice stabilizes the second modification of SrAlF5 and the tetrago
nal superlattice structure of Ca0.33Sr0.67AlF5 (I4(1)/a (No. 88), a = 19.73
45(3), c = 14.1982(2) Angstrom, Z = 64, R[F-2 > 2 sigma (F-2)] = 0.039, ome
gaR(2)(F-2 all) = 0.099) is obtained. delta -BaAlF5 is the fourth modificat
ion of BaAlF5 so far; it crystallizes in the triclinic system, P (1) over b
ar (No. 2), a = 5.2146(7), b = 7.3933(10), c = 14.946(2) Angstrom, alpha =
79.365(2)degrees, beta = 88.525(2)degrees, gamma = 88.183(2)degrees, Z = 6,
R[F-2 > 2 sigma (F-2)] = 0.033, omegaR(2)(F-2 all) = 0.089. The delta -BaA
lF5 crystals show ferroelastic behaviour; no first order phase transition c
ould be observed up to 580 degreesC. The bridging fluorine atoms are disord
ered around one Al atom. The relations between different BaAlF5 polymorphs
are briefly discussed. (C) 2001 Editions scientifiques et medicales Elsevie
r SAS. All rights reserved.